BOSTON SCIENTIFIC CORPORATION Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) of $468.00 million for the 62-month period ending 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostCostIncurredToDate · last filed 2014-05-08
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2011-03-31 was -$377.00M.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2010-12-31 was $30.00M.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, cost incurred to date (deprecated 2014-01-31) for the quarter ending 2010-09-30 was $17.00M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 3 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 6 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 9 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 29 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 32 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 33 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 36 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 38 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 39 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 41 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 42 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 44 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 48 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 50 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 53 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 53 month as first filed | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 60 month | Restructuring and Related Cost, Cost Incurred to Date (Deprecated 2014-01-31) 62 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $468.00M 10-Q · filed 2014-05-08 | |||||||||||||||||
| 2013-12-31 | $600.00M 10-K · filed 2014-02-26 | |||||||||||||||||
| 2013-06-30 | $547.00M 10-Q · filed 2013-11-05 | $521.00M 10-Q · filed 2013-08-07 | ||||||||||||||||
| 2013-03-31 | $490.00M 10-Q/A · filed 2013-05-07 | |||||||||||||||||
| 2012-12-31 | $476.00M 8-K · filed 2013-05-29 | |||||||||||||||||
| 2012-09-30 | $424.00M 10-Q · filed 2012-11-06 | |||||||||||||||||
| 2012-06-30 | $366.00M 10-Q · filed 2012-08-07 | |||||||||||||||||
| 2012-03-31 | $335.00M 10-Q · filed 2012-05-03 | |||||||||||||||||
| 2011-12-31 | $318.00M 10-K · filed 2012-02-17 | |||||||||||||||||
| 2011-09-30 | $296.00M 10-Q · filed 2011-11-08 | |||||||||||||||||
| 2011-06-30 | $269.00M 10-Q · filed 2011-08-05 | $427.00M 10-Q · filed 2011-08-05 | ||||||||||||||||
| 2011-03-31 | -$377.00M derived: 10-Q 42 month − 10-K 39 month · filed 2011-05-05 | -$347.00M derived: sum of 2 quarters · filed 2011-05-05 | -$330.00M derived: sum of 3 quarters · filed 2011-05-05 | $239.00M 10-Q · filed 2011-05-05 | ||||||||||||||
| 2010-12-31 | $30.00M derived: 10-K 39 month − 10-Q 36 month · filed 2011-02-17 | $47.00M derived: sum of 2 quarters · filed 2011-02-17 | $616.00M 10-K · filed 2011-02-17 | |||||||||||||||
| 2010-09-30 | $17.00M derived: 10-Q 36 month − 10-Q 33 month · filed 2010-11-05 | $586.00M 10-Q · filed 2010-11-05 | ||||||||||||||||
| 2010-06-30 | $569.00M 10-Q · filed 2010-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |